Irradiation as an Alternative to Mastectomy for Early Breast Cancer—An Important Consideration Because of Changes in Laws
AUTOR(ES)
Martinez, Alvaro
RESUMO
Between May 1973 and December 1980 there were 76 patients (78 breasts) with clinical stage I or II breast carcinoma treated by biopsy and definitive radiotherapy at Stanford University Medical Center. Local-regional control has been achieved thus far in 76 of 78 cases (97 percent) with a median follow-up time of 26 months. Transient lymphedema of the breast, arm edema and breast fibrosis were the most commonly noted complications. The cosmetic result was analyzed and scored as excellent in 78 percent, satisfactory in 18 percent and unsatisfactory in 4 percent. The three unsatisfactory results occurred in patients in whom severe fibrosis developed as a result of suboptimal radiation techniques. Interdisciplinary cooperation among surgical, medical and radiation oncologists is important. The 97 percent local-regional control and the 96 percent excellent-to-satisfactory results support the use of primary radiotherapy in early stage breast carcinoma.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1010786Documentos Relacionados
- HER2 status in breast cancer—an example of pharmacogenetic testing
- Computer simulation in conjunction with medical thermography as an adjunct tool for early detection of breast cancer
- Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy?
- Lymphangioma secondary to irradiation after mastectomy
- IRRADIATION THERAPY IN CANCER OF THE BREAST *